3Brafman BH, Bilaniuk LT, Naidich TP, et al. Magnetic resonance imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review [ J ]. Radiology, 1992,183 ( 1 ) :227.
4Caldemeyer KS,Mirowski GW. Tuberous sclerosis, part I : clinical and central nervous system findings [ J ]. J Am Acad Dermatol, 2001,45 ( 3 ) :448.
5Sener RN. Tuberous sclerosis: diffusion MRI findings in the brain [ J ].Eur Radiol, 2002,12 ( 1 ) : 138.
6Jansen FE, Braun KP, Nieuwenhuizen OV, et al. Diffusion weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis [J]. Arch Neurol, 2003,60(11 ) :1 580.
7Garaci FG, Floris R, Bozzao A, et al. Increased brain apparent diffusion coefficient in tuberous sclerosis [ J ]. Radiology,2004,232 (2) :461.
4Brafman BH,Bilaniuk LT,Naidich TP,et al.Magnetic resonance imaging of tuberous sclerosis;pathogenesis of this phakomatosis,of gadopentetate dimeglumine,and literature review[J].Radiology,1992,183:227-238.
6Kato T,Yamanouchi H,Sugaj K,et al.Improved detection of cortical and subcortical tubers in tuberous sclerosis by fluid-attenuated inversion recovery MRI[J].Neuroradiology,1997,39:378-380.
7Michael G,Kennelly H,Barton,G,et al.Outcome analysis of 43 cases of renal angiomyolipoma[J].J Urol,1994,152:1988-1991.
